Alerts will be sent to your verified email
Verify EmailGENNEX
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gennex Laboratories Ltd specializes in the production and export of bulk drugs and intermediates such as Guaiphenesin, Methocarbamol, Fluconazole, and Phenazopyridine.
Gennex Lab major competitors are Zim Laboratories, Trident Lifeline, Vaidya Sane Ayur Lab, Lyka Labs, Albert David, Brooks Laboratories, Ambalal Sarabhai Ent.
Market Cap of Gennex Lab is ₹353 Crs.
While the median market cap of its peers are ₹303 Crs.
Gennex Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jun | ||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|